Sortilins: New players in lipoprotein metabolism

Current Opinion in Lipidology

Volumn 22, Issue 2, 2011, Pages 79-85

  Willnow, Thomas E ^a,c   Kjølby, Mads ^b   Nykjaer, Anders ^b  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b AARHUS UNIVERSITY   (Denmark)

^c NONE   (Germany)

Author keywords

1p13.3; SORLA LR11; SORT1; sortilin; vacuolar protein sorting 10 protein domain receptors

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B100; CELL PROTEIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; SORTILIN;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DYSLIPIDEMIA; EVIDENCE BASED PRACTICE; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; VASCULAR SMOOTH MUSCLE;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; ATHEROSCLEROSIS; HUMANS; LDL-RECEPTOR RELATED PROTEINS; LIPOPROTEINS;

EID: 79953740539     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0b013e3283416f2b     Document Type: Article

References (52)

1. Willnow TE, Petersen CM, Nykjaer A. VPS10P-domain receptors: regulators of neuronal viability and function. Nat Rev Neurosci 2008; 9:899-909.
2. Petersen CM, Nielsen MS, Nykjaer A, et al. Molecular identification of a novel candidate sorting receptor purified from human brain by receptor-associated protein affinity chromatography. J Biol Chem 1997; 272:3599-3605. (Pubitemid 27066865)
3. Yamazaki H, Bujo H, Kusunoki J, et al. Elements of neural adhesion molecules and a yeast vacuolar protein sorting receptor are present in a novel mammalian low density lipoprotein receptor family member. J Biol Chem 1996; 271:24761-24768. (Pubitemid 26333222)
4. Jacobsen L, Madsen P, Moestrup SK, et al. Molecular characterization of a novel human hybrid-type receptor that binds the alpha2-macroglobulin receptor-associated protein. J Biol Chem 1996; 271:31379-31383. (Pubitemid 26408589)
5. Hermey G, Riedel IB, Hampe W, et al. Identification and characterization of SorCS, a third member of a novel receptor family. Biochem Biophys Res Commun 1999; 266:347-351. (Pubitemid 30028671)
6. Rezgaoui M, Hermey G, Riedel IB, et al. Identification of SorCS2, a novel member of the VPS10 domain containing receptor family, prominently expressed in the developing mouse brain. Mech Dev 2001; 100:335-338. (Pubitemid 32109345)
7. Hampe W, Rezgaoui M, Hermans-Borgmeyer I, Schaller HC. The genes for the human VPS10 domain-containing receptors are large and contain many small exons. Hum Genet 2001; 108:529-536. (Pubitemid 32700356)
8. Quistgaard EM, Madsen P, Groftehauge MK, et al. Ligands bind to Sortilin in the tunnel of a ten-bladed beta-propeller domain. Nat Struct Mol Biol 2009; 16:96-98.
9. Munck Petersen C, Nielsen MS, Jacobsen C, et al. Propeptide cleavage conditions sortilin/neurotensin receptor-3 for ligand binding. EMBO J 1999; 18:595-604. (Pubitemid 29057244)
10. Jacobsen L, Madsen P, Jacobsen C, et al. Activation and functional characterization of the mosaic receptor SorLA/LR11. J Biol Chem 2001; 276:22788-22796.
11. Marcusson EG, Horazdovsky BF, Cereghino JL, et al. The sorting receptor for yeast vacuolar carboxypeptidase Y is encoded by the VPS10 gene. Cell 1994; 77:579-586. (Pubitemid 24153997)
12. Nielsen MS, Madsen P, Christensen EI, et al. The sortilin cytoplasmic tail conveys Golgi-endosome transport and binds the VHS domain of the GGA2 sorting protein. EMBO J 2001; 20:2180-2190. (Pubitemid 32410588)
13. Nielsen MS, Gustafsen C, Madsen P, et al. Sorting by the cytoplasmic domain of the amyloid precursor protein binding receptor SorLA. Mol Cell Biol 2007; 27:6842-6851. (Pubitemid 47483634)
14. Mari M, Bujny MV, Zeuschner D, et al. SNX1 defines an early endosomal recycling exit for sortilin and mannose 6-phosphate receptors. Traffic 2008; 9:380-393. (Pubitemid 351188997)
15. Seaman MN. Identification of a novel conserved sorting motif required for retromer-mediated endosome-to-TGN retrieval. J Cell Sci 2007; 120:2378-2389. (Pubitemid 47225941)
16. Schmidt V, Sporbert A, Rohe M, et al. SorLA/LR11 regulates processing of amyloid precursor protein via interaction with adaptors GGA and PACS-1. J Biol Chem 2007; 282:32956-32964. (Pubitemid 350159299)
17. Muhammad A, Flores I, Zhang H, et al. Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and Abeta accumulation. Proc Natl Acad Sci USA 2008; 105:7327-7332. (Pubitemid 351754477)
18. Taira K, Bujo H, Hirayama S, et al. LR11, a mosaic LDL receptor family member, mediates the uptake of ApoE-rich lipoproteins in vitro. Arterioscler Thromb Vasc Biol 2001; 21:1501-1506. (Pubitemid 34219815)
19. Nielsen MS, Jacobsen C, Olivecrona G, et al. Sortilin/neurotensin receptor-3 binds and mediates degradation of lipoprotein lipase. J Biol Chem 1999; 274:8832-8836. (Pubitemid 29164682)
20. Nilsson SK, Christensen S, RaarupMK, et al. Endocytosis of apolipoprotein AV by members of the low density lipoprotein receptor and the VPS10p domain receptor families. J Biol Chem 2008; 283:25920-25927.
21. Shi J, Kandror KV. Sortilin is essential and sufficient for the formation of Glut4 storage vesicles in 3T3-L1 adipocytes. Dev Cell 2005; 9:99-108. (Pubitemid 40903663)
22. Chen ZY, Ieraci A, Teng H, et al. Sortilin controls intracellular sorting of brainderived neurotrophic factor to the regulated secretory pathway. J Neurosci 2005; 25:6156-6166. (Pubitemid 40923482)
23. Zhou B, Zhuang J, Gu D, et al. WNK4 enhances the degradation of NCC through a sortilin-mediated lysosomal pathway. J Am Soc Nephrol 2010; 21:82-92.
24. Wahe A, Kasmapour B, Schmaderer C, et al. Golgi-to-phagosome transport of acid sphingomyelinase and prosaposin is mediated by sortilin. J Cell Sci 2010; 123:2502-2511.
25. Zeng J, Racicott J, Morales CR. The inactivation of the sortilin gene leads to a partial disruption of prosaposin trafficking to the lysosomes. Exp Cell Res 2009; 315:3112-3124.
26. Dodson SE, Gearing M, Lippa CF, et al. LR11/SorLA expression is reduced in sporadic Alzheimer disease but not in familial Alzheimer disease. J Neuropathol Exp Neurol 2006; 65:866-872. (Pubitemid 44371232)
27. Rogaeva E, Meng Y, Lee JH, et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 2007; 39:168-177. (Pubitemid 46184347)
28. Andersen OM, Willnow TE. Lipoprotein receptors in Alzheimer's disease. Trends Neurosci 2006; 29:687-694. (Pubitemid 44779850)
29. Kanaki T, Bujo H, Hirayama S, et al. Expression of LR11, a mosaic LDL receptor family member, is markedly increased in atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1999; 19:2687-2695. (Pubitemid 29536044)
30. Zhu Y, Bujo H, Yamazaki H, et al. Enhanced expression of the LDL receptor family member LR11 increases migration of smooth muscle cells in vitro. Circulation 2002; 105:1830-1836. (Pubitemid 34408894)
31. Jiang M, Bujo H, Zhu Y, et al. Pitavastatin attenuates the PDGF-induced LR11/uPA receptor-mediated migration of smooth muscle cells. Biochem Biophys Res Commun 2006; 348:1367-1377. (Pubitemid 44291351)
32. Ohwaki K, Bujo H, Jiang M, et al. A secreted soluble form of LR11, specifically expressed in intimal smooth muscle cells, accelerates formation of lipid-laden macrophages. Arterioscler Thromb Vasc Biol 2007; 27:1050-1056. (Pubitemid 46641956)
33. Jiang M, Bujo H, Ohwaki K, et al. Ang II-stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice. J Clin Invest 2008; 118:2733-2746.
34. Takahashi M, Bujo H, Jiang M, et al. Enhanced circulating soluble LR11 in patients with coronary organic stenosis. Atherosclerosis 2010; 210:581-584.
35. Ma QL, Galasko DR, Ringman JM, et al. Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid. Arch Neurol 2009; 66:448-457.
36. Nilsson SK, Lookene A, Beckstead JA, et al. Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family. Biochemistry 2007; 46:3896-3904. (Pubitemid 46493490)
37. O'Brien PJ, Alborn WE, Sloan JH, et al. The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins. Clin Chem 2005; 51:351-359. (Pubitemid 40175805)
38. Ishihara M, Kujiraoka T, Iwasaki T, et al. A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration. J Lipid Res 2005; 46:2015-2022. (Pubitemid 41248499)
39. Pennacchio LA, Olivier M, Hubacek JA, et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 2001; 294:169-173. (Pubitemid 32952971)
40. Merkel M, Loeffler B, Kluger M, et al. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycanbound lipoprotein lipase. J Biol Chem 2005; 280:21553-21560. (Pubitemid 40805722)
41. Jansen P, Giehl K, Nyengaard JR, et al. Roles for the pro-neurotrophin receptor sortilin in neuronal development, aging and brain injury. Nat Neurosci 2007; 10:1449-1457. (Pubitemid 350014687)
42. Nykjaer A, Lee R, Teng KK, et al. Sortilin is essential for proNGF-induced neuronal cell death. Nature 2004; 427:843-848. (Pubitemid 38297746)
43. Kathiresan S, Melander O, Guiducci C, et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 2008; 40:189-197. (Pubitemid 351171402)
44. Willer CJ, Speliotes EK, Loos RJ, et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 2009; 41:25-34.
45. Aulchenko YS, Ripatti S, Lindqvist I, et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 2009; 41:47-55.
46. Muendlein A, Geller-Rhomberg S, Saely CH, et al. Significant impact of chromosomal locus 1p13.3 on serum LDL cholesterol and on angiographically characterized coronary atherosclerosis. Atherosclerosis 2009; 206:494-499.
47. Schadt EE, Molony C, Chudin E, et al. Mapping the genetic architecture of gene expression in human liver. PLoS Biol 2008; 6:e107.
48. Linsel-Nitschke P, Heeren J, Aherrahrou Z, et al. Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease. Atherosclerosis 2010; 208:183-189.
49. Musunuru K, Strong A, Frank-Kamenetsky M, et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 2010; 466:714-719.
50. Kjølby M, Andersen OM, Breiderhoff T, et al. Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export. Cell Metab 2010; 12:213-223.
51. Tissir F, Qu Y, Montcouquiol M, et al. Lack of cadherins Celsr2 and Celsr3 impairs ependymal ciliogenesis, leading to fatal hydrocephalus. Nat Neurosci 2010; 13:700-707.
52. Olofsson SO, Bostrom P, Andersson L, et al. Lipid droplets as dynamic organelles connecting storage and efflux of lipids. Biochim Biophys Acta 2009; 1791:448-458.